Cargando…
Structure-Based Epitope Design: Toward a Greater Antibody–SARS-CoV-2 RBD Affinity
[Image: see text] Efficient COVID-19 vaccines are widely acknowledged as the best way to end the global pandemic. SARS-CoV-2 receptor-binding domain (RBD) plays fundamental roles related to cell infection. Antibodies could be developed to target RBD and represent a potential approach for the neutral...
Autores principales: | Traboulsi, Hassan, Khedr, Mohammed A., Al-Faiyz, Yasair S. S., Elgorashe, Rafea, Negm, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637584/ https://www.ncbi.nlm.nih.gov/pubmed/34869973 http://dx.doi.org/10.1021/acsomega.1c03348 |
Ejemplares similares
-
Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes
por: Traboulsi, Hassan, et al.
Publicado: (2022) -
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
por: Yang, Lin, et al.
Publicado: (2021) -
Multi-Walled Carbon Nanotubes Functionalized with Hydroxamic Acid Derivatives for the Removal of Lead from Wastewater: Kinetics, Isotherm, and Thermodynamic Studies
por: Al-Faiyz, Yasair S. S., et al.
Publicado: (2022) -
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
por: Haycroft, Ebene R., et al.
Publicado: (2023) -
Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)